These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22790044)

  • 1. [Evaluation of modified OPTIMOX1 plus bevacizumab as the neoadjuvant therapy for highly advanced rectal cancers].
    Hirano A; Koda K; Suzuki M; Yamazaki M; Tezuka T; Kosugi C; Imai K; Nakagawa R; Adachi K; Shiragami R; Yasuda H
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1087-91. PubMed ID: 22790044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Preoperative Chemotherapy with Modified OPTIMOX-1 Plus Bevacizumab in Patients with Advanced Rectal Cancer with Factors Contraindicative of Curative Surgery.
    Kosugi C; Koda K; Tanaka K; Suzuki M; Yamazaki M; Shuto K; Matsuo K; Hirano A; Arimitsu H; Shiragami R; Yasuda H
    Hepatogastroenterology; 2015 Jun; 62(140):868-72. PubMed ID: 26902018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
    Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
    Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
    Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic abdominosacral resection for locally advanced primary rectal cancer after treatment with mFOLFOX6 plus bevacizumab, followed by preoperative chemoradiotherapy.
    Nagasaki T; Akiyoshi T; Ueno M; Fukunaga Y; Nagayama S; Fujimoto Y; Konishi T; Yamaguchi T
    Asian J Endosc Surg; 2014 Jan; 7(1):52-5. PubMed ID: 24450344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two cases of advanced rectal cancer resected successfully after neoadjuvant chemotherapy with FOLFOX regimen].
    Shimizu H; Taniguchi F; Sonoda H; Itokawa Y; Ikeda J; Yamashita T; Koide K; Ueshima Y; Takashina K; Lee CJ; Shioaki Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2073-5. PubMed ID: 20037327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complete clinical and pathological response to mFOLFOX6 neoadjuvant chemotherapy in a case of advanced rectal cancer].
    Mori K; Kikunaga H; Morisue A; Fujita K; Ishikawa K; Sakuragawa T; Kumai K; Miura H; Mikami S
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):679-82. PubMed ID: 22504702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
    Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pilot study of preoperative mFOLFOX6 chemotherapy for advanced rectal cancers which were difficult to ensure surgical margins].
    Maeda K; Noda E; Nagahara H; Inoue T; Kashiwagi S; Fuyuhiro Y; Nakamoto K; Hirakawa K
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1297-300. PubMed ID: 21829067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
    Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case with liver resection of metastasis from rectal cancer after FOLFOX4+bevacizumab treatment].
    Kojima T; Matsui T; Uemura T; Fujimitsu Y; Kure N; Kojima H
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1761-3. PubMed ID: 18931584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial.
    Xiao J; Chen Z; Li W; Yang Z; Huang Y; Zheng J; Deng Y; Wang L; Ren D; Peng J; Lan P; Wang J
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):21-7. PubMed ID: 25952796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Repeated resections for originally unresectable liver metastasis from colorectal cancer after multiagent chemotherapy].
    Kobayashi H; Uetake H; Higuchi T; Enomoto M; Iida S; Ishikawa T; Ishiguro M; Kato S; Matsuyama T; Ono H; Yamauchi S; Masuda D; Sugihara K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2301-3. PubMed ID: 22202362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of neoadjuvant chemotherapy for locally advanced rectal cancer, which had a invasion into the vagina followed by curative resection].
    Kimura K; Kagawa Y; Kato T; Ishida T; Morimoto Y; Matusita K; Kusama H; Hashimoto T; Katura Y; Nitta K; Takeno A; Nakahira S; Okishiro M; Sakisaka H; Taniguchi H; Egawa C; Takeda Y; Tamura S
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1740-2. PubMed ID: 25731314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of resected rectal cancer with hepatic node and multiple liver metastases effectively treated by preoperative modified FOLFOX6 and sLV5FU2 chemotherapy].
    Seshimo K; Oishi M; Toshima T; Ikeda H; Kato H; Yamamura M; Kodera M; Yamashita Y; Tanaka N; Fujita H; Shibagaki K; Taniguchi H; Matsuki T; Kobayashi K; Takita K
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):477-80. PubMed ID: 22421784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FOLFIRI with bevacizumab chemotherapy for a patient with recurrence of rectal cancer under haemodialysis for chronic renal failure].
    Hoshino H; Ishii Y; Hasegawa H; Endo T; Ochiai H; Hoshino Y; Matsunaga A; Shigeta K; Seo Y; Hoshino G; Kitagawa Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):983-6. PubMed ID: 22705698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of advanced rectal cancer treated effectively with intersphincteric resection and preoperative chemotherapy].
    Kimura A; Nishikawa S; Yachi T; Ito Y; Kudo Y; Kubo N; Tokura T; Umehara Y; Kurushima M; Takahashi K; Morita T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2201-3. PubMed ID: 23268023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer].
    Kuwabara H; Baba H; Wakabayashi M; Nakamura H; Sanada T; Baba H; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2250-2. PubMed ID: 22202345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of bevacizumab for advanced colorectal cancer].
    Naito M; Hoshino S; Noda N; Nakano M; Matsuo K; Yamauchi Y; Shinohara T; Tanaka S; Yamashita Y
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):83-8. PubMed ID: 20087037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.